WHO European Region's strategy for elimination of measles and congenital rubella infection.
The WHO strategy for measles elimination in Europe includes the strengthening of surveillance and immunisation programmes in collaboration with European specific networks (EUVAC.NET and CCEE-Baltic) and Member States.
Hanon
F-X
FX
World Health Organization Regional Office for Europe, Copenhagen, Denmark.
Spika John
J
J
Wassilak Steven
S
S
Emiroglu
N
N
D017677:Age Distribution; D000914:Antibodies, Viral / Q000096:biosynthesis; D004196:Disease Outbreaks / Q000517:prevention & control / Q000706:statistics & numerical data; D005060:Europe / Q000453:epidemiology; D005260:Female; D006801:Humans; D017589:Immunization Programs; D015994:Incidence; D008457:Measles / Q000453:epidemiology / Q000517:prevention & control*; D008458:Measles Vaccine / Q000627:therapeutic use*; D008459:Measles virus / Q000276:immunology*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control; D012410:Rubella Syndrome, Congenital / Q000453:epidemiology / Q000517:prevention & control*; D012411:Rubella Vaccine / Q000627:therapeutic use*; D012412:Rubella virus / Q000276:immunology*; D018571:Sentinel Surveillance; D014944:World Health Organization
D000914:Antibodies, Viral; D008458:Measles Vaccine; D012411:Rubella Vaccine